Hepatorenal syndrome: a Nationwide Trend Analysis from 2008 to 2018.
Hepatorenal syndrome
liver cirrhosis
mortality
nationwide inpatient sample
outcomes
trends
Journal
Annals of medicine
ISSN: 1365-2060
Titre abrégé: Ann Med
Pays: England
ID NLM: 8906388
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
pubmed:
6
1
2022
medline:
22
3
2022
entrez:
5
1
2022
Statut:
ppublish
Résumé
This study was designed to assess the epidemiological trends and outcomes associated with Hepatorenal Syndrome (HRS). This retrospective interrupted trend study used the Nationwide Inpatient Sample (NIS) database for the years 2008, 2012, 2014, 20z16 and 2018 to identify adult (≥18 years) hospitalizations with a primary diagnosis of HRS. We determined epidemiological characteristics and trends for HRS hospitalizations. Additionally, we also calculated the inpatient mortality, mean length of stay (LOS) and mean total hospital charge (THC) using a multivariate regression trend analysis. There was an increase in the total number of HRS hospitalizations from 22,864 in 2008 to 42,985 in 2018 with a trend towards increasing hospitalizations ( Total hospitalizations, hospitalizations for women and the mean age for HRS hospitalizations were on the rise between 2008 and 2018. However, the inpatient mortality declined.KEY MESSAGESIn the United States, there was a trend towards increasing hospitalizations and mean age for HRS.Although a male predominance was noted, HRS hospitalizations for women were on the rise.The inpatient mortality for HRS hospitalizations was on a decline and may indicate significant improvements in management.
Identifiants
pubmed: 34985399
doi: 10.1080/07853890.2021.1998595
pmc: PMC8604523
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2018-2024Références
Clin Gastroenterol Hepatol. 2018 Feb;16(2):162-177.e1
pubmed: 28602971
Hepatology. 2008 Dec;48(6):2064-77
pubmed: 19003880
Am J Kidney Dis. 2016 Feb;67(2):318-28
pubmed: 26500178
Am J Kidney Dis. 2011 Dec;58(6):928-38
pubmed: 21962618
Clin Gastroenterol Hepatol. 2010 Jul;8(7):616-22; quiz e80
pubmed: 20399905
J Hepatol. 2015 Nov;63(5):1272-84
pubmed: 26192220
Curr Med Res Opin. 2017 Aug;33(8):1473-1480
pubmed: 28509578
Gastroenterol Res Pract. 2015;2015:207012
pubmed: 25649410
Gut. 2007 Sep;56(9):1310-8
pubmed: 17389705
Dig Dis Sci. 2011 Apr;56(4):977-87
pubmed: 20844956
Gastroenterology. 1993 Jul;105(1):229-36
pubmed: 8514039
Gastroenterol Hepatol. 2022 Jan;45(1):25-39
pubmed: 33746028
Clin Biochem Rev. 2007 Feb;28(1):11-7
pubmed: 17603637
Int J Nephrol. 2016;2016:8419719
pubmed: 27144022
Gastroenterology. 2005 Dec;129(6):1944-53
pubmed: 16344063
Dig Dis Sci. 2020 May;65(5):1539-1548
pubmed: 31571102
Ann Intensive Care. 2017 Dec;7(1):33
pubmed: 28321803
Hepatol Int. 2020 Mar;14(2):167-179
pubmed: 32128705
World J Hepatol. 2013 Dec 27;5(12):685-91
pubmed: 24432185
World J Gastroenterol. 2018 Jun 7;24(21):2300-2310
pubmed: 29881239
J Clin Transl Hepatol. 2020 Jun 28;8(2):192-199
pubmed: 32832400
J Med Econ. 2019 May;22(5):421-429
pubmed: 30724682
Nephron. 2015;131(3):191-201
pubmed: 26485256
J Investig Med. 2014 Oct;62(7):920-6
pubmed: 25203153
J Hepatol. 2015 Apr;62(4):968-74
pubmed: 25638527
Health Serv Res. 2018 Feb;53(1):175-196
pubmed: 27873305
Semin Intervent Radiol. 2015 Dec;32(4):445-54
pubmed: 26622108
World J Gastroenterol. 2007 Nov 14;13(42):5552-9
pubmed: 17948928
Hepatology. 2005 Jun;41(6):1282-9
pubmed: 15834937
PLoS One. 2020 Sep 18;15(9):e0239393
pubmed: 32946502
J Clin Gastroenterol. 2015 Sep;49(8):690-6
pubmed: 25291348